Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Journal of Comparative Effectiveness Research : 2022 year in review51
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary41
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis41
Access in all areas? A round-up of developments in market access and health technology assessment: part 1036
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database35
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis32
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis30
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea27
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy27
Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison23
Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 04123
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis23
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies22
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 2021
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study20
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims18
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis18
Access in all areas? A round-up of developments in market access and health technology assessment: first Joint Clinical Assessment report released18
0.36305999755859